Perflutren

5 trials 1 recruiting VVarious

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

1 Recruiting

1 Completed trials

5 Sponsors

9 Countries

Phase III

Phase II

Phase I/II

Phase IV

Phase III: 1 Phase II: 2 Phase I/II: 1 Phase IV: 1

Oversight events:

9 temporary halts across 1 trial

View oversight register →

Indications tested

Acute myocardial infarction 1 Sjogren's syndrome 1 Glioblastoma 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 1 Carthera 1 Karolinska Institutet 1 Novartis Pharma AG 1 Solstice Pharmaceuticals B.V. 1

All trials

5 total

Safety, Tolerability, and Imaging Quality of HarMono-T Contrast Agent During Ultrasound of the Kidney in Healthy Subjects Not authorised

2024-514924-17-00 Phase I/II 1 country Solstice Pharmaceuticals B.V.
Multisite open-label randomized phase II clinical trial in newly diagnosed glioblastoma treated by concurrent TemoRadiation and adjuvant tem… Pending

2024-511880-27-00 Phase II 2 countries Assistance Publique Hopitaux De Paris
RandomizEd compariSOn of apixaban versus warfarin in patients with Left VEntricular thrombus after Acute Myocardial Infarction (RESOLVE-AMI)… Recruiting

2024-514416-28-00 Phase IV 2 countries Karolinska Institutet
A randomized, open-label, multicentric, two-arm pivotal trial of SonoCloud-9 combined with carboplatin (CBDCA) vs standard of care lomustine… Halted

2023-505829-14-00 Phase III 9 countries Carthera
Biopsy Based Study to Understand Mechanism of Action of Ianalumab in Salivary Glands and Explore Relationships with Clinical Assessments Ended

2023-508957-24-00 Phase II 1 country Novartis Pharma AG

Showing 1–5 of 5 trials

← All drugs A–Z